2Zaremba T, Curtin NJ. PARP inhibitor development for systemic cancer targeting [J], Anticancer Agents MedChem, 2007,7(5): 515-523. 被引量：1
3Rouleau M, Patel A, Hendzel M J, et al. PARP inhibition: PARP1 and beyond [J]. Nat Rev Cancer, 2010,10(4):293-301. 被引量：1
4Bauer PI, Buki KG, Hakam A, Kun E. Macromolecular association of ADP-ribosyltransferase and its correlation with enzymic actMtv [J]. Biochem J. 1990.270:17-26. 被引量：1
5Mendoza-Alvarez H, Alvarez-Gonzalez R. Poly (ADP-ribose) polymerase is a catalytic dimer and the automodification reaction is intermolecular [J]. J Biol Chem, 1993,268:22575- 22580. 被引量：1
6Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP- ribose polymerases [J]. Front Biosci, 2008,13:3046-3082. 被引量：1
7Chambon P, Weill JD, Mandel P. Nicotinamide mononucleotide activation of new DNA-dependent polyadenylic acid synthesizing nuclear enzyme [J], Biochem Biophys Res Commun, 1963,11:39-43. 被引量：1
8Durkacz BW, Omidiji O, Gray DA, et al. (ADP-ribose)n participates in DNA excision repair [J]. Nature, 1980,283 ( 5747 ) :593 - 596. 被引量：1
9Wang M, Wu W, Rosidi B, et al. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways [J]. Nucleic Acids Res, 2006,34(21):6170-6182. 被引量：1
10Hirschhorn R. In vivo reversion to normal of inherited mutations in humans [J]. J Med Genet, 2003,40(10):721-728. 被引量：1
1Dent R,Trudeau M,Pritchard KJ,et al.Triple-negative breast cancer:clinical feature and patterns of recurrence[J].Clin Cancer Res,2011,17(13):4429-4434. 被引量：1
2Prou CM,Sorlie T,Eisen MB,et al.Molecular portrait of human breast tumor[J].Nature,2010,406(26):747-752. 被引量：1
3Liedtke C,Brogliok,Moulder S,et al.Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer[J].Ann Oncol,2009,20(12):1953-1958. 被引量：1
4Nielsen TO,Hsu FD,Jensen K,et al.Immunohistochemical and clnical-characterization of the basal,like subtype of iiivasive.breast carcinoma[J].Clin Cancer Res,2004,15(10):5367-5374. 被引量：1
5Carey LA,Perou CM,Livasy CA,et al.Breast cancer subtypes,and surviral in the Carolina breast cancer study[J].JAMA,2006,295(21):2492-2502. 被引量：1
6Rakha EA,El-Sayed ME,Green AR,et al.Prognostic markers in triple-negative breast cancer[J].Cancer,2007,109(21):25-32. 被引量：1
7Hoeller D,Crosetto N,Blagoer B,et al.Regulation of ubiquitin-binding proteins by monubiquitination[J].Nat CellBiol,2010,8(2):163-169. 被引量：1
8Yan J,Kim YS,Yang XP,et al.Ubiquitin-interaction motifs of RAP 80are eritical in its regulation of estrogen receptor alpha[J].Nucleic Acids Res,2012,35(5):1673-1686. 被引量：1
9Bakha KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor(PR)-negative,and HER2-negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California Cancer Registry[J].Cancer,2007,19(11):1721-1728. 被引量：1
10Kim MJ,Roj Y,Ahn SH,et al.Clinnicopatholgic significance of the basal-like subtype of breast cancer:A comparison with hormone receptor and Her2/neu-overexpressing phenotypes[J].Eur J Cancer,2010,32(1):63-69. 被引量：1
